ClinicalTrials.Veeva

Menu

Observational Study Conducted on Patients Receiving the ESOP 2 Stem to Confirm Security and Performance of the Device (ESOP2)

F

FH ORTHO

Status

Enrolling

Conditions

Hip Fractures
Hip Disease

Treatments

Device: Hip prosthesis - ESOP 2 cementless femoral stem

Study type

Observational

Funder types

Industry

Identifiers

NCT04193163
2018-37

Details and patient eligibility

About

This study is a post-market clinical follow-up conducted in order to collect long-term data on security and performance of the ESOP 2 stem, which is intended to be implanted in case of total hip replacement, when used in real life conditions according to the instructions for use.

Full description

The primary objective of this study is to evaluate the security of the ESOP 2 stem by calculating the survival rate up to 10 years of follow-up.

The secondary objectives are to evaluate the security and performance of the device by assessing radiological data, gathering complications and evaluating functional score and quality of life score up to 10 years of follow-up.

Enrollment

268 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Subject implanted with ESOP 2 stem in one of the following indication according to the instructions for use: hip disorders; femoral neck fracture
  • Subject who received an information form and is willing to participate in the study

Exclusion criteria

  • Contraindications described in the instructions for use
  • Usual surgical contraindications
  • Subject who is not able to express his/her non-opposition

Trial design

268 participants in 1 patient group

Patients receiving ESOP 2 stem
Treatment:
Device: Hip prosthesis - ESOP 2 cementless femoral stem

Trial contacts and locations

7

Loading...

Central trial contact

Clinical Project Leader

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems